Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Chung, Shiu Dong ^a,b,c   Liu, Shih Ping ^d   Lin, Herng Ching ^c,e   Wang, Li Hsuan ^c,e  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; ANTINEOPLASTIC AGENT; GONADORELIN;

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HOSPITALIZATION; HUMAN; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PNEUMONIA; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; AGONISTS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; PROSTATIC NEOPLASMS; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PNEUMONIA; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84903388898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101254     Document Type: Article

References (14)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA. Cancer J Clin 61: 69-90.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, et al (2012) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49: 1374-1403.
3. Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate Cancer. N Engl J Med 349: 366-81. (Pubitemid 36886244)
4. Schröder F, Crawford ED, Axcrona K, Payne H, Keane TE (2012) Androgen deprivation therapy: past, present and future. BJU International 109: 1-12.
5. Labrie F, Bélanger A, Luu-The V (2005) Gonadotropin-releaseing hormone agonists in the treatment of prostate cancer. Endocr Rev 26: 361-79. (Pubitemid 40686649)
6. García-Gómez E, González-Pedrajo B, Camacho-Arroyo I (2013) Role of sex steroid hormones in bacterial-host interactions. Biomed. Res Int Article ID 928290.
7. Klein SL (2000) The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 24: 627-638.
8. Quintar A A, Leimgruber C, Pessah O A, Doll A, Maldonado CA (2012) Androgen depletion augments antibacterial prostate host defences in rats. Int J Androl 35: 845-859.
9. Chen YC, Yeh HY, Wu JC, Haschler I, Chen TJ, Wetter T (2011) Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 86: 365-380.
10. Ojeda MS, Scardapane EGL, Gimenez MS (2003) Morphologic and biochemical changes in male rat lung after surgical and pharmacological castration. Braz J Med Biol Res 33: 279-285. (Pubitemid 30196167)
11. Ojeda MS, Gomez N, Gimenez MS (1997) Androgen regulation of lung lipids in the male rat. Lipids 32: 57-62. (Pubitemid 27057301)
12. Plotkin BJ, Roose RJ, Erikson Q,Viselli SM (2003) Effect of androgens and glucocorticoids on microbial growth and antimicrobial susceptibility. Curr Microbiol 47: 514-520. (Pubitemid 37443152)
13. Kosyreva AM (2013) Histophysiology of immune system and barrier organs in the late period of orchiectomy in wistar rats. Bull Exp Biol Med 154: 480-484.
14. Chuang KH, Altuwaijri S, Li G (2009) Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J Exp Med 206: 1181-1199.